• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素和熊果酸对前列腺癌的影响:系统评价。

Effects of curcumin and ursolic acid in prostate cancer: A systematic review.

机构信息

Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.

Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, USA.

出版信息

Urologia. 2024 Feb;91(1):90-106. doi: 10.1177/03915603231202304. Epub 2023 Sep 30.

DOI:10.1177/03915603231202304
PMID:37776274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10976464/
Abstract

The major barriers to phytonutrients in prostate cancer therapy are non-specific mechanisms and bioavailability issues. Studies have pointed to a synergistic combination of curcumin (CURC) and ursolic acid (UA). We investigate this combination using a systematic review process to assess the most likely mechanistic pathway and human testing in prostate cancer. We used the PRISMA statement to screen titles, abstracts, and the full texts of relevant articles and performed a descriptive analysis of the literature reviewed for study inclusion and consensus of the manuscript. The most common molecular and cellular pathway from articles reporting on the pathways and effects of CURC ( = 173) in prostate cancer was NF-κB ( = 25, 14.5%). The most common molecular and cellular pathway from articles reporting on the pathways and effects of UA ( = 24) in prostate cancer was caspase 3/caspase 9 ( = 10, 41.6%). The three most common molecular and cellular pathway from articles reporting on the pathways and effects of both CURC and UA ( = 193) in prostate cancer was NF-κB ( = 28, 14.2%), Akt ( = 22, 11.2%), and androgen ( = 19, 9.6%). Therefore, we have identified the potential synergistic target pathways of curcumin and ursolic acid to involve NF-κB, Akt, androgen receptors, and apoptosis pathways. Our review highlights the limited human studies and specific effects in prostate cancer.

摘要

植物化学素在前列腺癌治疗中的主要障碍是非特异性机制和生物利用度问题。研究表明,姜黄素(CUR)和熊果酸(UA)的协同组合。我们通过系统评价过程研究了这种组合,以评估其在前列腺癌中最可能的机制途径和人体试验。我们使用 PRISMA 声明筛选标题、摘要和相关文章的全文,并对文献进行描述性分析,以评估研究纳入和手稿共识。在报道 CUR 在前列腺癌中的途径和作用的文章( = 173)中,最常见的分子和细胞途径是 NF-κB( = 25,14.5%)。在报道 UA 在前列腺癌中的途径和作用的文章( = 24)中,最常见的分子和细胞途径是 caspase 3/caspase 9( = 10,41.6%)。在报道 CUR 和 UA 在前列腺癌中的途径和作用的文章( = 193)中,最常见的三个分子和细胞途径是 NF-κB( = 28,14.2%)、Akt( = 22,11.2%)和雄激素( = 19,9.6%)。因此,我们已经确定了姜黄素和熊果酸的潜在协同作用靶点途径,涉及 NF-κB、Akt、雄激素受体和凋亡途径。我们的综述强调了在前列腺癌中人类研究和特定作用的局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/41c291f3b8d9/10.1177_03915603231202304-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/0bb01f55ff6d/10.1177_03915603231202304-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/4d964de13b4a/10.1177_03915603231202304-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/2b7cfcff5400/10.1177_03915603231202304-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/9915e604238b/10.1177_03915603231202304-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/41c291f3b8d9/10.1177_03915603231202304-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/0bb01f55ff6d/10.1177_03915603231202304-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/4d964de13b4a/10.1177_03915603231202304-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/2b7cfcff5400/10.1177_03915603231202304-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/9915e604238b/10.1177_03915603231202304-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/10976464/41c291f3b8d9/10.1177_03915603231202304-fig5.jpg

相似文献

1
Effects of curcumin and ursolic acid in prostate cancer: A systematic review.姜黄素和熊果酸对前列腺癌的影响:系统评价。
Urologia. 2024 Feb;91(1):90-106. doi: 10.1177/03915603231202304. Epub 2023 Sep 30.
2
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
3
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.双膦酸盐或 RANK 配体抑制剂治疗前列腺癌伴骨转移的男性患者:一项网状荟萃分析。
Cochrane Database Syst Rev. 2020 Dec 3;12(12):CD013020. doi: 10.1002/14651858.CD013020.pub2.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Recent advances in the molecular targeted drugs for prostate cancer.前列腺癌分子靶向药物的最新进展。
Int Urol Nephrol. 2023 Apr;55(4):777-789. doi: 10.1007/s11255-023-03487-3. Epub 2023 Jan 31.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.

引用本文的文献

1
Ursolic acid derivative UA312 ameliorates ionizing radiation-induced cardiotoxicity and neurodevelopmental toxicity in zebrafish via targeting chrna3 and grik5.熊果酸衍生物UA312通过靶向chrna3和grik5改善斑马鱼中电离辐射诱导的心脏毒性和神经发育毒性。
Acta Pharmacol Sin. 2025 Apr 28. doi: 10.1038/s41401-025-01564-0.
2
Antioxidant Senotherapy by Natural Compounds: A Beneficial Partner in Cancer Treatment.天然化合物抗氧化衰老疗法:癌症治疗中的有益伙伴
Antioxidants (Basel). 2025 Feb 10;14(2):199. doi: 10.3390/antiox14020199.
3
Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.

本文引用的文献

1
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.临床局限性前列腺癌:AUA/ASTRO 指南,第 I 部分:介绍、风险评估、分期和基于风险的管理。
J Urol. 2022 Jul;208(1):10-18. doi: 10.1097/JU.0000000000002757. Epub 2022 May 10.
2
A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options.关键转录因子 NF-κB 作为癌症治疗靶点及其抑制剂作为癌症治疗选择。
Curr Med Chem. 2021;28(21):4117-4132. doi: 10.2174/0929867327666201111142307.
3
Correction to Codelivery of Natural Compounds with a Dual-Targeted Nanoparticle Delivery System for Improving Synergistic Therapy in an Orthotopic Tumor Model.
肥胖、饮食干预与微生物群改变在前列腺癌发生发展中的作用
Front Immunol. 2025 Jan 7;15:1448116. doi: 10.3389/fimmu.2024.1448116. eCollection 2024.
4
Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules.评估脂质增强胶囊中姜黄素与熊果酸组合的安全性、生物利用度和肠道微生物群的1期临床试验。
J Tradit Complement Med. 2024 Mar 7;14(5):558-567. doi: 10.1016/j.jtcme.2024.03.002. eCollection 2024 Sep.
5
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential.姜黄素及其类似物在口腔鳞状细胞癌中的研究现状与治疗潜力
Anticancer Agents Med Chem. 2025;25(5):313-329. doi: 10.2174/0118715206297840240510063330.
用于改善原位肿瘤模型中协同治疗的双靶向纳米颗粒递送系统对天然化合物的共递送校正
ACS Appl Mater Interfaces. 2020 Apr 22;12(16):19244. doi: 10.1021/acsami.0c05903. Epub 2020 Apr 8.
4
Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer.使用经CD133适配体修饰的表面递送姜黄素纳米脂质体用于前列腺癌治疗
Drug Des Devel Ther. 2019 Nov 28;13:4021-4033. doi: 10.2147/DDDT.S210949. eCollection 2019.
5
Synthesis of novel 4-Boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells.新型 4-Boc-哌啶酮查耳酮的合成及其对高转移性癌细胞的细胞毒性活性评价。
Bioorg Med Chem Lett. 2020 Jan 1;30(1):126760. doi: 10.1016/j.bmcl.2019.126760. Epub 2019 Oct 28.
6
Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting.载姜黄素的丝胶接枝多功能氟化氧化石墨烯纳米药物具有荷质转变性能,可有效靶向癌细胞。
Int J Pharm. 2019 Dec 15;572:118791. doi: 10.1016/j.ijpharm.2019.118791. Epub 2019 Oct 31.
7
Investigating the Multi-Target Pharmacological Mechanism of Willd Acting on Prostate Cancer: A Network Pharmacology Approach.基于网络药理学研究威灵仙治疗前列腺癌的多靶作用机制。
Biomolecules. 2019 Oct 9;9(10):591. doi: 10.3390/biom9100591.
8
Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.姜黄素对激素依赖性和非依赖性转移性前列腺癌细胞基因表达的影响。
Int J Mol Sci. 2019 Oct 2;20(19):4891. doi: 10.3390/ijms20194891.
9
Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system .通过单壁碳纳米管递药系统增强姜黄素的抗肿瘤疗效和进一步光热消融肿瘤生长
Drug Deliv. 2019 Dec;26(1):1017-1026. doi: 10.1080/10717544.2019.1672829.
10
Impregnation of Curcumin into a Biodegradable (Poly-lactic-co-glycolic acid, PLGA) Support, to Transfer Its Well Known In Vitro Effect to an In Vivo Prostate Cancer Model.姜黄素浸渍于可生物降解(聚乳酸-共-羟基乙酸,PLGA)载体中,将其体外的显著效果转移到体内前列腺癌模型中。
Nutrients. 2019 Sep 29;11(10):2312. doi: 10.3390/nu11102312.